Difficulties of evaluation of the results of drug treatment of schizophrenia
Welbel, L.
Psychiatria Polska 14(1): 51-57
1980
ISSN/ISBN: 0033-2674 PMID: 6102774 Document Number: 164383
Document emailed within 1 workday
Related Documents
Schooler, N.R.; Keith, S.J.; Severe, J.B.; Matthews, S. 1989: Acute treatment response and short term outcome in schizophrenia: first results of the NIMH treatment strategies in schizophrenia study. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 331-335Martyniak, K.; Wyczółkowski, M.; Bochiński, T. 1985: Evaluation of early results of treatment of pulmonary tuberculosis in Mycobacterium-positive patients. Comparison of the results of 3- and 4-drug treatment Pneumonologia Polska 53(4): 195-201
Fujii, Y. 2001: Acute phase drug therapy and drug switching in the treatment of patients with schizophrenia Seishin Shinkeigaku Zasshi 103(12): 1030-1035
Sergiacomo, L.; Ciancaglini, R.; Orlando, D.; Delle Monache, G.; Pesa, O. 1986: Treatment of alcoholic hepatic steatosis with metadoxine. Preliminary results on the evaluation of the effects of the drug by an ultrasonographic study La Clinica Terapeutica 119(2): 133-141
Davis, J.M.; Andriukaitis, S. 1986: The natural course of schizophrenia and effective maintenance drug treatment Journal of Clinical Psychopharmacology 6(1 Suppl): 2s
Andrzejewska, E.; Pasik, G.; Siwczyński, J. 1980: Difficulties of diagnosis of schizophrenia in juvenile delinquents Psychiatria Polska 14(3): 307-311
Gülseren, L. 2002: Schizophrenia and the family: difficulties, burdens, emotions, needs Turk Psikiyatri Dergisi 13(2): 143-151
Tarazi, F.I.; Shahid, M. 2009: Asenapine maleate: a new drug for the treatment of schizophrenia and bipolar mania Drugs of Today 45(12): 865-876
Taylor, D. 2001: Atypical antipsychotics in the treatment of schizophrenia. Pragmatic considerations are important when considering which drug to prescribe Bmj 322(7291): 925; Author Reply 927-8
Hargreaves, W.A.; Kane, J.M.; Ninan, P.T.; Severe, J.B.; Woerner, M. 1989: Demographic characteristics, treatment history, presenting psychopathology and early course in schizophrenia. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 340-343
Verachai, V.; Punjawatnun, J.; Perfas, F. 2003: The results of drug dependence treatment by therapeutic community in Thanyarak Institute on Drug Abuse Journal of the Medical Association of Thailand 86(5): 407-414
Isoniemi, H.; Eklund, B.; Höckerstedt, K.; Korsbäck, C.; Salmela, K.; von Willebrand, E.; Häyry, P.; Ahonen, J. 1990: Discontinuation of one drug in triple drug treatment of renal allograft patients: 1-year results Transplantation Proceedings 22(4): 1365-1366
Hartmann, W.; Meyer, J.E. 1974: Clinical treatment of chronic schizophrenia in the Federal German Republic. Results and consequences Der Nervenarzt 45(2): 1-8
Gelenberg, A.J.; Doller, J.C. 1979: Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study Journal of Clinical Psychiatry 40(5): 238-240
Schooler, N.R.; Levine, J.; Severe, J.B. 1979: Depot fluphenazine in the prevention of relapse in schizophrenia: evaluation of a treatment regimen Psychopharmacology Bulletin 15(2): 44-47
Burkovskiĭ, G.V.; Vuks, A.I.; Iovlev, B.V.; Korabel'nikov, K.V.; Shchelkova, O.I. 1990: Study of the effectiveness of individual computer-assisted prediction of the results of rehabilitation treatment of patients with schizophrenia Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 90(7): 94-99
Thakore, J.H.; Mann, J.N.; Vlahos, I.; Martin, A.; Reznek, R. 2002: Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 26(1): 137-141
Nakayasu, N.; Seki, Y.; Harima, H. 1999: Age of onset, frequency of the development of symptoms, and treatment outcome in the early stage of schizophrenia--in search of guidelines for early diagnosis and treatment of schizophrenia Seishin Shinkeigaku Zasshi 101(11): 898-907
Domke, I.; Cremer, P.; Huchtemann, M. 2000: Therapeutic Drug Monitoring on COBAS® INTEGRA 400 - Evaluation Results Clinical Laboratory 46(9-10): 509-515
Slopek, S.; Durlakowa, I.; Weber-Dabrowska, B.; Kucharewicz-Krukowska, A.; Dabrowski, M.; Bisikiewicz, R. 1983: Results of bacteriophage treatment of suppurative bacterial infections. II. Detailed evaluation of the results Archivum Immunologiae et Therapiae Experimentalis 31(3): 293-327